Shanghai Fosun Pharmaceutical Raises Stake in United Health Insurance; Shares Rise
Shanghai Fosun Pharmaceutical (Group) (HKG:2196) signed a Share Subscription Agreement with IFC and ADB to invest 270 million yuan each in United Health Insurance, according to a Monday filing with the Hong Kong bourse.
The deal will increase Fosun Pharma's stake in the insurer from 14.00% to 20.05%. The capital infusion, totaling 810 million yuan, will support the company's expansion. The transaction does not require the approval of independent shareholders.
Fosun Pharma views this investment as a strategic move to enhance its presence in China's rapidly growing health insurance sector.
The pharmaceuticals shares were up 6% in Hong Kong and 4% in Shanghai in recent trading.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。